Author: Nuclearmedicine

Is PRRT Right for You | Nuclear Medicine Therapy

How do you determine whether PRRT is the recommended mode of treatment for your condition?... Read More

Lutetium-177 labelled prostate-specific membrane antigen (177Lu-PSMA) is a promising new therapeutic approach to treat metastatic prostate cancer which has been approved recently by the FDA in the treatment of metastatic... Read More

The Department of Nuclear Medicine at the Fortis Memorial Research Institute (FMRI), Gurugram, has been one of the apex centres in the country practising Radio-theranostics since 2013.... Read More

Explore the future of medical imaging with Siemens Healthineers Biograph Vision. Dive into the advanced capabilities and transformative technology beyond digital PET/CT for cutting-edge healthcare solutions.... Read More

Hepato Cellular Carcinoma (HCC) Clinical Trial

Glypican-3 (GPC3) is an oncofetal glycoprotein attached to the cell membrane. The expression of GPC3 is seen in various tumors, most notably in hepatocellular carcinomas(HCCs). Since GPC3 is not expressed... Read More